GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Return-on-Tangible-Asset

EZZ Life Science Holdings (ASX:EZZ) Return-on-Tangible-Asset : 12.05% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. EZZ Life Science Holdings's annualized Net Income for the quarter that ended in Dec. 2023 was A$2.28 Mil. EZZ Life Science Holdings's average total tangible assets for the quarter that ended in Dec. 2023 was A$18.95 Mil. Therefore, EZZ Life Science Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 12.05%.

The historical rank and industry rank for EZZ Life Science Holdings's Return-on-Tangible-Asset or its related term are showing as below:

ASX:EZZ' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 9.99   Med: 17.17   Max: 22.78
Current: 19.71

During the past 4 years, EZZ Life Science Holdings's highest Return-on-Tangible-Asset was 22.78%. The lowest was 9.99%. And the median was 17.17%.

ASX:EZZ's Return-on-Tangible-Asset is ranked better than
97.29% of 1550 companies
in the Biotechnology industry
Industry Median: -40.42 vs ASX:EZZ: 19.71

EZZ Life Science Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for EZZ Life Science Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Return-on-Tangible-Asset Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Return-on-Tangible-Asset
- 17.17 9.99 22.78

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial 1.68 18.67 17.79 28.62 12.05

Competitive Comparison of EZZ Life Science Holdings's Return-on-Tangible-Asset

For the Biotechnology subindustry, EZZ Life Science Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Return-on-Tangible-Asset falls into.



EZZ Life Science Holdings Return-on-Tangible-Asset Calculation

EZZ Life Science Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=3.63/( (14.246+17.622)/ 2 )
=3.63/15.934
=22.78 %

EZZ Life Science Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=2.284/( (17.622+20.278)/ 2 )
=2.284/18.95
=12.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


EZZ Life Science Holdings  (ASX:EZZ) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


EZZ Life Science Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines